ETSA winner Theranautilus heads to human trials; JSW One’s IPO plans
AI Summary
Theranautilus is set to begin human trials of its nanorobot-based dental tech soon. This and more in today’s ETtech Morning Dispatch.
Discussion
Sign in to join the discussion.
Loading comments…